• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Vibegron Intermediate CAS:1421271-01-3
Food Grade Fish Collagen
Vibegron Intermediate CAS:1295539-30-8
Vibegron Intermediate CAS:1426235-01-9
Vibegron Intermediate CAS:163625-46-5
Vibegron Intermediate

Philippines gets 1 million more Sinovac doses

firstwordpharmaJune 07, 2021

Tag: Sinovac , COVID-19 , Vaccine

The Philippines on Sunday received 1 million more doses of Sinovac's COVID-19 vaccine as part of its procurement of the vaccine, as reported The Philippine Star.

Philippines gets 1 million more Sinovac doses

The shipment brought the number of Sinovac doses in the country to 6.5 million, of which around 1 million were donated by Beijing.

Vaccine czar Carlito Galvez Jr. has said the country is expecting around 10 million doses to arrive this month.

Other vaccines in the country aside from Sinovac are: AstraZeneca and Pfizer from the COVAX Facility and Sputnik V from Russia.

Previous:Anvisa allows import of Covaxin, Sputnik V into Brazil, but conditions apply

Next:Understanding molecular actions may be key in treating severe COVID-19 cases: Study

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

Philippines gets 1 million more Sinovac doses | Pharmasources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

You may like
More>>

Trivalent Influenza Vaccine

Trivalent Influenza Vaccine
Hualan flu vaccine

Hualan flu vaccine
Hualan Quadrivalent Influenza Vaccine

Hualan Quadrivalent Influenza Vaccine
high standard and safety Influenza A (H1N1) Vaccine, (Split, Inactivated)

high standard and safety Influenza A (H1N1) Vaccine, (Split, Inactivated)
Influenza A (H1N1) Vaccine, (Split, Inactivated)by Hualan biological 1

Influenza A (H1N1) Vaccine, (Split, Inactivated)by Hualan biological 1
2023-2024 flu vaccine

2023-2024 flu vaccine
Hualan Biological Influenza Vaccine

Hualan Biological Influenza Vaccine
High-quality Influenza Vaccine (Split virion), inactivated

High-quality Influenza Vaccine (Split virion), inactivated
Influenza Vaccine in Syringe of Hualan Bio

Influenza Vaccine in Syringe of Hualan Bio
Influenza Vaccine in 2022

Influenza Vaccine in 2022

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service